Article
FGFR2 Inhibition in Cholangiocarcinoma.
Annual review of medicine - 27 Jan 2023
Vogel Arndt, Segatto Oreste, Stenzinger Albrecht, Saborowski Anna
Abstract excerpt
Biliary tract cancer (BTC) is the second most common primary liver cancer after hepatocellular carcinoma and accounts for 2% of cancer-related deaths. BTCs are classified according to their anatomical origin into intrahepatic (iCCA), perihilar, or distal cholangiocarcinoma, as well as gall bladder carcinoma. While the mutational profiles in these anatomical BTC subtypes overlap to a large extent, iCCA is notable...
Topics
Join the communities discussing this publication.